Equities research analysts forecast that AxoGen, Inc (NASDAQ:AXGN) will post earnings of ($0.08) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have ma
ALACHUA, Fla., Feb. 05, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral.
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report fourth quarter and fu
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
TransMedics Group (NASDAQ:TMDX) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their inst
Karen Zaderej became the CEO of AxoGen, Inc. (NASDAQ:AXGN) in 2011. First, this article will compare CEO compensation...
Wall Street brokerages expect AxoGen, Inc (NASDAQ:AXGN) to post ($0.08) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for AxoGen’s earnin
BidaskClub lowered shares of AxoGen (NASDAQ:AXGN) from a sell rating to a strong sell rating in a report released on Friday morning, BidAskClub reports. Several other brokerages also recently issued r

85 Biggest Movers From Yesterday

12:00am, Tuesday, 14'th Jan 2020
AxoGen (NASDAQ:AXGN) announces preliminary Q4 and FY 2019 revenue guidance.Q4 and FY revenue is expected to be at least $28.1M and $106.6M, respectively.Ended Q4 with 109 direct sales representatives
AxoGen sees FY20 revenue $124M-$128M, consensus $132.38M AXGN
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE